Search clinical trials for: MK0736

Total 168 results

Organon and Co

Completed

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)

Asthma | Allergic Rhinitis
Organon and Co

Completed

Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)

Androgenetic Alopecia
Organon and Co

Completed

Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)

Bronchiolitis
Organon and Co

Completed

Exercise Induced Bronchoconstriction (0476-359)

Asthma, Exercise-induced
Organon and Co

Completed

A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)

Asthma
Organon and Co

Completed

Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

Asthma | Rhinitis Allergic
Organon and Co

Completed

An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)

Rhinitis, Allergic, Seasonal
Merck Sharp & Dohme LLC

Completed

A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)

Osteoarthritis
Merck Sharp & Dohme LLC

Completed

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)

Postoperative Pain
Merck Sharp & Dohme LLC

Completed

A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)

HIV Infections
Merck Sharp & Dohme LLC

Completed

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

Obesity and Obesity-related Medical Conditions
Organon and Co

Completed

SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363) (STAR)

Asthma
Organon and Co

Completed

To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)

Asthma
Merck Sharp & Dohme LLC

Completed

Sitagliptin Added-on to Insulin Study (0431-051)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)

Prostate Cancer
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of MK0773 in Healthy Older Men (0773-004)

Healthy
Cancer Research UK

Completed

MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery

Pancreatic Cancer

United Kingdom
Merck Sharp & Dohme LLC

Completed

An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)

Diabetes Mellitus, Type 2 | Chronic Renal Insufficiency
Organon and Co

Completed

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)

Asthma
Merck Sharp & Dohme LLC

Completed

A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)

Postoperative Pain
Merck Sharp & Dohme LLC

Completed

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)

Postoperative Pain
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome

Pain

France
Organon and Co

Withdrawn

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

Bone Neoplasms
Organon and Co

Completed

A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)

Rheumatoid Arthritis,Osteoarthritis
Organon and Co

Completed

Analgesic Treatment Mediated by Arcoxia (0663-093)

Pain
Organon and Co

Completed

Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)

Rheumatoid Arthritis
Merck Sharp & Dohme LLC

Completed

A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)

Smoking
Merck Sharp & Dohme LLC

Completed

An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

Obesity
Organon and Co

Completed

An Investigational Drug in Patients With Osteoarthritis (0663-073)

Osteoarthritis
Merck Sharp & Dohme LLC

Completed

A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)

Diabetes Mellitus, Type II
Merck Sharp & Dohme LLC

Completed

MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)

Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC

Terminated

A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)

Pain
Merck Sharp & Dohme LLC

Terminated

A Study of MK0364 in Obese Patients (0364-014)

Obesity
Organon and Co

Completed

Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)

Pain
Merck Sharp & Dohme LLC

Completed

A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)

Osteoarthritis
Merck Sharp & Dohme LLC

Completed

MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Terminated

A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)

Obesity
Organon and Co

Completed

The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)

Asthma
University of Erlangen-Nürnberg Medical School
Merck Sharp & Dohme LLC; Rush University Medical Center; HELIOS Kliniken GmbH

Terminated

Modulation of the Surgical Inflammatory Response by Etoricoxib

Pain | Postoperative Pain | Osteoarthritis, Hip

Germany
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)

Colorectal Adenoma
Merck Sharp & Dohme LLC

Completed

A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

Diabetes Mellitus, Type 2
Organon and Co

Completed

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

Recurrent Low Back Pain
Organon and Co

Completed

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

Recurrent Low Back Pain
Organon and Co

Completed

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

Asthma
Organon and Co

Completed

MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)

Rhinitis Allergic
Merck Sharp & Dohme LLC

Completed

A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

Rheumatoid Arthritis
Organon and Co

Completed

A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)

Osteoarthritis

3

Subscribe